These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Dysimmune and inflammatory myopathies].
    Author: Authier FJ.
    Journal: Rev Prat; 2008 Dec 31; 58(20):2253-60. PubMed ID: 19209656.
    Abstract:
    Dysimmunes and inflammatory myopathies (DIM) are divided in four groups, on the grounds of clinical and histopathological criteria: dermatomyositis, polymyositis, inclusion body myositis and autoimmune necrotizing myopathy. They may present as unique condition (primary DIM), or in association with cancer (paraneoplastic DIM) or connective tissue disease (overlap syndrome). All of them but inclusion body myositis usually respond to immunomodulatory therapy, including steroids, immunosuppressive drugs, and intravenous immunglobulins. However, most often they are chronic diseases with relapses and therapeutic failure.
    [Abstract] [Full Text] [Related] [New Search]